Cargando…
P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431333/ http://dx.doi.org/10.1097/01.HS9.0000846296.62306.db |
| _version_ | 1784780025687441408 |
|---|---|
| author | Hiemstra, I. H. Santegoets, K. Janmaat, M. L. Ten Hagen, W. Van Dooremalen, S. De Goeij, B. E. Bosgra, S. Sasser, A. K. Breij, E. C. |
| author_facet | Hiemstra, I. H. Santegoets, K. Janmaat, M. L. Ten Hagen, W. Van Dooremalen, S. De Goeij, B. E. Bosgra, S. Sasser, A. K. Breij, E. C. |
| author_sort | Hiemstra, I. H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431333 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313332022-08-31 P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO Hiemstra, I. H. Santegoets, K. Janmaat, M. L. Ten Hagen, W. Van Dooremalen, S. De Goeij, B. E. Bosgra, S. Sasser, A. K. Breij, E. C. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431333/ http://dx.doi.org/10.1097/01.HS9.0000846296.62306.db Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Hiemstra, I. H. Santegoets, K. Janmaat, M. L. Ten Hagen, W. Van Dooremalen, S. De Goeij, B. E. Bosgra, S. Sasser, A. K. Breij, E. C. P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO |
| title | P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO |
| title_full | P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO |
| title_fullStr | P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO |
| title_full_unstemmed | P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO |
| title_short | P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO |
| title_sort | p854: hexabody-cd38 induces trogocytosis and effectively induces complement-mediated tumor cell lysis after treatment with daratumumab or isatuximab in vitro |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431333/ http://dx.doi.org/10.1097/01.HS9.0000846296.62306.db |
| work_keys_str_mv | AT hiemstraih p854hexabodycd38inducestrogocytosisandeffectivelyinducescomplementmediatedtumorcelllysisaftertreatmentwithdaratumumaborisatuximabinvitro AT santegoetsk p854hexabodycd38inducestrogocytosisandeffectivelyinducescomplementmediatedtumorcelllysisaftertreatmentwithdaratumumaborisatuximabinvitro AT janmaatml p854hexabodycd38inducestrogocytosisandeffectivelyinducescomplementmediatedtumorcelllysisaftertreatmentwithdaratumumaborisatuximabinvitro AT tenhagenw p854hexabodycd38inducestrogocytosisandeffectivelyinducescomplementmediatedtumorcelllysisaftertreatmentwithdaratumumaborisatuximabinvitro AT vandooremalens p854hexabodycd38inducestrogocytosisandeffectivelyinducescomplementmediatedtumorcelllysisaftertreatmentwithdaratumumaborisatuximabinvitro AT degoeijbe p854hexabodycd38inducestrogocytosisandeffectivelyinducescomplementmediatedtumorcelllysisaftertreatmentwithdaratumumaborisatuximabinvitro AT bosgras p854hexabodycd38inducestrogocytosisandeffectivelyinducescomplementmediatedtumorcelllysisaftertreatmentwithdaratumumaborisatuximabinvitro AT sasserak p854hexabodycd38inducestrogocytosisandeffectivelyinducescomplementmediatedtumorcelllysisaftertreatmentwithdaratumumaborisatuximabinvitro AT breijec p854hexabodycd38inducestrogocytosisandeffectivelyinducescomplementmediatedtumorcelllysisaftertreatmentwithdaratumumaborisatuximabinvitro |